Skip to main content

#158321

Anti-TNC-C

Cat. #158321

Anti-TNC-C

Cat. #: 158321

Sub-type: Primary antibody

Unit size: 100 ug

Availability: 10-12 weeks

Target: Tenascin-C C-domain

Class: Polyclonal

Application: ELISA ; IHC ; IF

Reactivity: Rabbit

Host: Rabbit

£300.00

This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.

Contributor

Inventor: Tambet Teesalu ; Prakash Lingasamy

Institute: University of Tartu

Tool Details
Target Details
Applications
Handling
References

Tool Details

*FOR RESEARCH USE ONLY (for other uses, please contact the licensing team)

  • Name: Anti-TNC-C
  • Alternate name: Polyclonal anti-TNC-C
  • Research fields: Cancer;Cell biology
  • Tool sub type: Primary antibody
  • Class: Polyclonal
  • Conjugation: Unconjugated
  • Reactivity: Rabbit
  • Host: Rabbit
  • Application: ELISA ; IHC ; IF
  • Description: Oncofetal fibronectin (FN-EDB) and tenascin-C C domain (TNC-C) are nearly absent in extracellular matrix of normal adult tissues but upregulated in malignant tissues. Both FN-EDB and TNC-C are developed as targets of antibody-based therapies.This series of antibodies has been validated in vitro against glioblastoma (GBM) and prostate carcinoma xenografts, and to non-malignant angiogenic neovessels induced by VEGF-overexpression. Please see our related anti-FN-EDB antibodies from University of Tartu.

Target Details

  • Target: Tenascin-C C-domain
  • Target background: Oncofetal fibronectin (FN-EDB) and tenascin-C C domain (TNC-C) are nearly absent in extracellular matrix of normal adult tissues but upregulated in malignant tissues. Both FN-EDB and TNC-C are developed as targets of antibody-based therapies. This series of antibodies has been validated in vitro against glioblastoma (GBM) and prostate carcinoma xenografts, and to non-malignant angiogenic neovessels induced by VEGF-overexpression. Please see our related anti-FN-EDB antibodies from Universit...

Applications

  • Application: ELISA ; IHC ; IF

Handling

  • Format: Liquid
  • Unit size: 100 ug
  • Shipping conditions: Dry ice

References

  • Lingasamy et al. 2019. Biomaterials. 219:119373. PMID: 31374479.

Tool enquiry

Please ensure you use your organisation email address rather than personal where possible, as this helps us locate your organisation in our system faster.

Please note we may take up to three days to respond to your enquiry.

CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.